- Category
- Micro (2020-21)
- Udyam number
- UDYAM-KR-12-0002218

Sansin Pharmaceutical Private Limited
About Sansin Pharmaceutical Private Limited
Data last updated:
Sansin Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC339710.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dinkar Dhavaja Naik and Chandranaik Santhosha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at L M Nagar Pada No. 4 Nr Sing Bus Stop Thane, Maharashtra, India – 400606.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.18 Lakh, a decline of 54% compared to the previous year. For the same year it recorded a net loss of ₹2.06 Lakh (net margin -16.9%) and EBITDA of -₹1.98 Lakh (EBITDA margin -16.2%).
Sansin Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-12-0002218).
Company details
Recognitions & Rankings of Sansin Pharmaceutical
Contact details
Sansin Pharmaceutical Private Limited's registered office is in Thane, Maharashtra.
- Registered AddressL M Nagar Pada No. 4 Nr Sing Bus Stop Thane, Maharashtra, India – 400606
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sansin Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Sansin Pharmaceutical Private Limited, buy the company report.
Financials of Sansin Pharmaceutical Private Limited
FY 2024 filings availableSansin Pharmaceutical Private Limited reported revenue of ₹12.18 Lakh (down 54% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 54% in the latest year. EBITDA fell 344% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.98 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2.06 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -16.2% | |||
| Net Profit Margin | -16.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sansin Pharmaceutical Private Limited, buy the company report.
Board of directors of Sansin Pharmaceutical Private Limited
Sansin Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinkar Dhavaja Naik | Director | 09 Mar 2021 | 5 Years 7 Months | Current |
| Chandranaik Santhosha | Director | 09 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Sansin Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mak & Mak Outsourcing & Services Private Limited | ₹12.24 Lakh (FY 2025) | -33.0% | Gurgaon, Haryana, India | |||
| Ayush Traditional Innovations Private Limited | ₹12.24 Lakh (FY 2024) | 3076.0% | New Delhi, Delhi, India | |||
| KBG Healthcare Private Limited | ₹12.2 Lakh (FY 2025) | Kolkata, West Bengal, India | ||||
| Tanisha Health Care Services Private Limited | ₹12.19 Lakh (FY 2024) | 5.0% | Jalandhar, Punjab, India | |||
| Satyaprabha Remedies Private Limited | ₹12.19 Lakh (FY 2025) | 43.0% | Delhi, India | |||
| Sansin Pharmaceutical Private Limitedthis company | ₹12.18 Lakh (FY 2024) | -₹2.06 Lakh | -16.9% | -54.0% | Thane, Maharashtra, India | |
| Saanvi Central Diagnostic Private Limited | ₹12.16 Lakh (FY 2024) | 23.0% | Chhatarpur, Madhya Pradesh, India | |||
| Ballant Healthcare Private Limited | ₹12.16 Lakh (FY 2019) | Ramanagara, Karnataka, India | ||||
| Kuerzen Biosolutions Private Limited | ₹12.16 Lakh (FY 2025) | 495.0% | Ator Nagla, Uttar Pradesh, India | |||
| Dragonfly Impex Private Limited | ₹12.15 Lakh (FY 2020) | 1487.0% | Chennai, Tamil Nadu, India | |||
| Biodeal Connects Private Limited | ₹12.14 Lakh (FY 2025) | 35.0% | Thane, Maharashtra, India |
To see the full peer comparison of Sansin Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sansin Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sansin Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sansin Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sansin Pharmaceutical Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Dinkar Dhavaja Naik was appointed as Director on 09 Mar 2021.
Frequently asked questions
Sansin Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 May 2020 (6+ years old) and is registered under CIN U51909MH2020PTC339710.
Sansin Pharmaceutical has 2 current directors:
- Dinkar Dhavaja Naik - Director
- Chandranaik Santhosha - Director
The latest financial statements of Sansin Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Sansin Pharmaceutical is U51909MH2020PTC339710. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sansin Pharmaceutical was incorporated on 09 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sansin Pharmaceutical by revenue are Mak & Mak Outsourcing & Services Private Limited, Ayush Traditional Innovations Private Limited, KBG Healthcare Private Limited, Tanisha Health Care Services Private Limited, Satyaprabha Remedies Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Dinkar Dhavaja Naik was appointed as Director on 09 Mar 2021. Rohit Singh ceased to be Director on 09 Mar 2021. Chandranaik Santhosha was appointed as Director on 09 May 2020.
Yes, Sansin Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-12-0002218).
The registered office of Sansin Pharmaceutical is at L M Nagar Pada No. 4 Nr Sing Bus Stop Thane, Maharashtra, India – 400606.
Sansin Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sansin Pharmaceutical can be reached at its registered office: L M Nagar Pada No. 4 Nr Sing Bus Stop Thane, Maharashtra, India – 400606.